Product Pathways
BCP0097 PF-2341066,Crizotinib
PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nnM, respectivley.
BCP0114 SB431542
Potent and selective inhibitor of the transforming growth factor-ß (TGF-ß) type I receptor activin receptor-like kinase ALK5 (IC50 = 94 nM), and its relatives ALK4 and ALK7.
BCP0082 NVP-TAE684
NVP-TAE684 is a highly potent and selective smallmolecule ALK inhibitor, which blocked the growth of ALCL-derived and ALK-dependent cell lines with IC50 values between 2 and 10 nM.
BCP0354 SB525334
SB525334 is a selective inhibitor of transforming growth factor-β receptor I (ALK5, TGF-βRI) (IC50=14.3 nM).
BCP000930 CH5424802
BCP001225 SB505124
BCP001297 ALK5 Inhibitor
BCP001602 A-83-01
BCP0006436 ASP3026
ASP3026 is a novel and selective inhibitor for the ALK kinase.
BCP0006648 AP26113
AP26113 is an orally available inhibitor of receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and the epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
第一页 1 2 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.